Stockreport

Merck's MilliporeSigma agrees to acquire Mirus Bio for $600m [Yahoo! Finance]

Arrowhead Pharmaceuticals, Inc.  (ARWR) 
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arrowheadpharma.com/investor-relations
PDF The move aims to enhance Merck's capabilities in viral vector manufacturing for cell and gene therapies. MilliporeSigma specialises in developing and commercialising [Read more]